Authors:
Aviezer, D
Seddon, AP
Wildey, MJ
Bohlen, P
Yayon, A
Citation: D. Aviezer et al., Development of a high throughput screening assay for inhibitors of fibroblast growth factor-receptor-heparin interactions, J BIOMOL SC, 6(3), 2001, pp. 171-177
Authors:
Dias, S
Hattori, K
Heissig, B
Zhu, ZP
Wu, Y
Witte, L
Hicklin, DJ
Tateno, M
Bohlen, P
Moore, MAS
Rafii, S
Citation: S. Dias et al., Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathwaysis essential to induce long-term remission of xenotransplanted human leukemias, P NAS US, 98(19), 2001, pp. 10857-10862
Authors:
Zimmermann, RC
Hartman, T
Bohlen, P
Sauer, MV
Kitajewski, J
Citation: Rc. Zimmermann et al., Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibitsangiogenesis in corpora lutea, MICROVASC R, 62(1), 2001, pp. 15-25
Authors:
Lu, D
Jimenez, X
Zhang, HF
Wu, Y
Bohlen, P
Witte, L
Zhu, ZP
Citation: D. Lu et al., Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor, CANCER RES, 61(19), 2001, pp. 7002-7008
Authors:
Kunkel, P
Ulbricht, U
Bohlen, P
Brockmann, MA
Fillbrandt, R
Stavrou, D
Westphal, M
Lamszus, K
Citation: P. Kunkel et al., Inhibition of glioma angiogenesis and growth in vivo by systemic treatmentwith a monoclonal antibody against vascular endothelial growth factor receptor-2, CANCER RES, 61(18), 2001, pp. 6624-6628
Authors:
Viloria-Petit, A
Crombet, T
Jothy, S
Hicklin, D
Bohlen, P
Schlaeppi, JM
Rak, J
Kerbel, RS
Citation: A. Viloria-petit et al., Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: A role for altered tumor angiogenesis, CANCER RES, 61(13), 2001, pp. 5090-5101
Authors:
Kozin, SV
Boucher, Y
Hicklin, DJ
Bohlen, P
Jain, RK
Suit, HD
Citation: Sv. Kozin et al., Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts, CANCER RES, 61(1), 2001, pp. 39-44
Authors:
Corada, M
Liao, F
Lindgren, M
Lampugnani, MG
Breviario, F
Frank, R
Muller, WA
Hicklin, DJ
Bohlen, P
Dejana, E
Citation: M. Corada et al., Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability, BLOOD, 97(6), 2001, pp. 1679-1684
Authors:
Ludwig, D
Lorenz, J
Dejana, E
Bohlen, P
Hicklin, DJ
Witte, L
Pytowski, B
Citation: D. Ludwig et al., cDNA cloning, chromosomal mapping, and expression analysis of human VE-Cadherin-2, MAMM GENOME, 11(11), 2000, pp. 1030-1033
Authors:
Klement, G
Baruchel, S
Rak, J
Man, S
Clark, K
Hicklin, DJ
Bohlen, P
Kerbel, RS
Citation: G. Klement et al., Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity, J CLIN INV, 105(8), 2000, pp. R15-R24
Authors:
Lu, D
Kussie, P
Pytowski, B
Persaud, K
Bohlen, P
Witte, L
Zhu, ZP
Citation: D. Lu et al., Identification of the residues in the extracellular region of KDR important for interaction with vascular endothelial growth factor and neutralizing anti-KDR antibodies, J BIOL CHEM, 275(19), 2000, pp. 14321-14330
Authors:
Liao, F
Li, YW
O'Connor, W
Zanetta, L
Bassi, R
Santiago, A
Overholser, J
Hooper, A
Mignatti, P
Dejana, E
Hicklin, DJ
Bohlen, P
Citation: F. Liao et al., Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitorof angiogenesis, tumor growth, and metastasis, CANCER RES, 60(24), 2000, pp. 6805-6810
Authors:
Zhu, ZP
Lu, D
Kotanides, H
Santiago, A
Jimenez, X
Simcox, T
Hicklin, DJ
Bohlen, P
Witte, L
Citation: Zp. Zhu et al., Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody, CANCER LETT, 136(2), 1999, pp. 203-213
Authors:
Lu, D
Kotanides, H
Jimenez, X
Zhou, QW
Persaud, K
Bohlen, P
Witte, L
Zhu, ZP
Citation: D. Lu et al., Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2, J IMMUNOL M, 230(1-2), 1999, pp. 159-171
Authors:
Prewett, M
Huber, J
Li, YW
Santiago, A
O'Connor, W
King, K
Overholser, J
Hooper, A
Pytowski, B
Witte, L
Bohlen, P
Hicklin, DJ
Citation: M. Prewett et al., Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors, CANCER RES, 59(20), 1999, pp. 5209-5218